Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05384145 · ClinicalTrials.gov registry record · NA

Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama

A NA study of HIV and HIV Testing, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05384145 is a NA study of HIV and HIV Testing that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 80 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05384145, a NA study of HIV and HIV Testing, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to adapt and evaluate a combination intervention that includes: (1) a data-driven approach to directed community-based HIV testing to areas with high need, (2) Project Connect to expedite linkage to care at time of diagnosis, (3) and a Rapid ART (antiretroviral therapy)Start program, all in Mobile County Health Department (MCHD) jurisdictions in Alabama.

Interventions

  • OTHER COAST-AL

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-03-27
Est. Completion 2027-05-31
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05384145

The ClinicalTrials.gov registry entry for NCT05384145 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which COAST-AL is the first listed.

NCT05384145 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05384145 about?

NCT05384145 is a clinical study titled "Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama". The purpose of this study is to adapt and evaluate a combination intervention that includes: (1) a data-driven approach to directed community-based HIV testing to areas with high need, (2) Project Connect to expedite linkage to care at time of diagnosis, (3) and a Rapid ART (antiretroviral therapy)S...

What is the current status of trial NCT05384145?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-03-27. Estimated completion is 2027-05-31.

What conditions does trial NCT05384145 study?

This clinical trial studies the following conditions: HIV, HIV Testing, HIV Treatment, HIV Linkage to Care.

What interventions are being tested in trial NCT05384145?

The interventions under investigation include: COAST-AL (OTHER).

Who is sponsoring clinical trial NCT05384145?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05384145 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.